Table of Contents

company-logo

Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

Hemostemix Dividend Announcement

• Hemostemix does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Hemostemix dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Hemostemix Dividend History

Hemostemix Dividend Yield

Hemostemix current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Hemostemix stock? Use our calculator to estimate your expected dividend yield:

Hemostemix Financial Ratios

P/E ratio-3.83
PEG ratio-1.30
P/B ratio-0.89
ROE25.45%
Payout ratio0.00%
Current ratio0.07
Quick ratio0.07
Cash Ratio0.03

Hemostemix Dividend FAQ

Does Hemostemix stock pay dividends?
Hemostemix does not currently pay dividends to its shareholders.
Has Hemostemix ever paid a dividend?
No, Hemostemix has no a history of paying dividends to its shareholders. Hemostemix is not known for its dividend payments.
Why doesn't Hemostemix pay dividends?
There are several potential reasons why Hemostemix would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Hemostemix ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Hemostemix has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Hemostemix a dividend aristocrat?
Hemostemix is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Hemostemix a dividend king?
Hemostemix is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Hemostemix a dividend stock?
No, Hemostemix is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Hemostemix stocks?
To buy Hemostemix you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Hemostemix stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.